MedPath

Improving Neurodevelopmental ouTcomes After Prenatal Cannabinoid in uTero Exposure

Not Applicable
Not yet recruiting
Conditions
Developmental Delay
Registration Number
NCT06423664
Lead Sponsor
IDeA States Pediatric Clinical Trials Network
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not yet recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Inclusion Criteria:<br><br>Birthing Parent<br><br> - Age of majority, as defined by the state of residency<br><br> - Cannabinoid use during pregnancy confirmed with self-report<br><br> - Have the ability to speak, read, and understand English<br><br> - Birthing parent who delivered at one of the hospitals where study team members have<br> clinical privileges to access medical records<br><br> - Has parental custody of the infant<br><br> - Singleton pregnancy with live birth<br><br> - Has an electronic device capable of watching videos and able to stream/download<br> videos for viewing and permitting video conferencing<br><br> - Has study access to the internet<br><br>Infant<br><br> - Term infants at birth (>37 weeks' gestation)<br><br> - Biological child of the birthing parent<br><br>Exclusion Criteria:<br><br>Birthing Parent<br><br> - Other illicit drug use, excluding cannabinoids, during pregnancy (such as heroin or<br> cocaine) per self-reported or toxicology results<br><br> - Opiate use (prescribed or unprescribed) per self-report or toxicology results during<br> this pregnancy<br><br> - Prolonged hospitalization following delivery longer than 7 days<br><br>Infant<br><br> - Has major birth defect(s) including physical anomalies including limb<br> malformations/absence of limbs or chromosomal abnormalities<br><br> - Diagnosed with neonatal encephalopathy, metabolic disorder, stroke, intracranial<br> hemorrhage, or meningitis during birth hospitalization<br><br> - Received any major surgical intervention during the birth hospitalization or<br> required a prolonged birth hospitalization (prolonged hospitalization being any<br> hospitalization longer than 7 days)

Exclusion Criteria

Not provided

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Percentage of approached participants that are eligible for study participation;Percentage of participants that complete their final visit;Percentage of participants that receive a sufficient number of coaching sessions
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath